Search for: "Mylan Inc."
Results 421 - 440
of 674
Sorted by Relevance
|
Sort by Date
2 Oct 2012, 12:49 pm
He’s also used his stakes to influence the direction of such companies as XO Communications, Mylan Laboratories, Time Warner Inc. and Mentor Graphics, among others. [read post]
12 Jul 2010, 9:40 am
Mylan Pharmaceuticals Inc., C.A. 09-184-... [read post]
23 Jan 2019, 10:08 am
Mylan Pharmaceuticals, Inc., et al. [read post]
13 Sep 2019, 11:09 am
Mylan Pharmaceuticals Inc., 896 F.3d 1332 (Fed. [read post]
16 May 2012, 12:22 pm
Mylan Pharmaceuticals, Inc., ___ F. [read post]
11 Nov 2017, 11:00 am
Mylan Institutional LLC, 846 F.3d1213, 1221–23 (Fed. [read post]
18 Mar 2010, 2:30 am
Mylan Pharmaceuticals, Inc. et al. [read post]
6 Nov 2015, 6:58 am
Mylan and Actavis were seeking revocation of the patent. [read post]
28 Dec 2009, 7:57 am
The case is still proceeding against Dey, Inc., Mylan Pharmaceuticals, Inc., Sandoz, Inc. and their parent companies. [read post]
11 Nov 2010, 12:54 pm
Mylan Pharmaceuticals, Inc., 2010 WL 3339274, at *3 (W.D. [read post]
11 May 2011, 4:54 am
Allergan, Inc. [read post]
19 Dec 2008, 1:00 pm
$16.8 million for Alphapharm and Mylan: Takeda v Mylan (Patent Baristas) (Patent Docs) Boniva (Ibandronic acid) – US: Apotex challenges validity of Hoffmann-La Roche’s Boniva patent (Law360) Boniva (Ibandronic acid) – US: Orchid Chemicals & Pharmaceuticals and Orgenus Pharma seek declaratory judgment of invalidity and noninfringement in patent infringement suit brought by Hoffmann-La Roche over Boniva (Law360) Cardizem (Diltiazem) –… [read post]
3 Jun 2009, 5:49 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Singulair (Montelukast) – US: Merck & Co’s Singulair patent challenged on $50K bounty (Patent Baristas) (GenericsWeb) General Docs at BIO (Panel addresses narrowing scope of biotech patents – Patent Docs), (‘Perfect storm’ super session – Patent Docs) (Biotech… [read post]
23 Dec 2009, 12:40 am
Sandoz Limited (EPLAW) Fuzeon (Enfuvirtide) - US: If there are no sources of proof in the E D of Texas, expect to transferred: In re Hoffman-La Roche Inc (Filewrapper) Gemzar (Gemcitabine) – US: Eli Lilly appeals from grant of partial summary judgment finding certain claims invalid for double patenting: Sun Pharma v Eli Lilly (PATracer) Gemzar (Gemcitabine) – US: Eli Lilly files patent infringement complaint against APP Pharmaceuticals following Para IV challenge (Patent Docs)… [read post]
22 Jul 2009, 6:05 am
(PatLit) Levaquin (Levofloxacin) – US: CAFC awards only partial costs where depositions used in multiple cases from different district courts: Ortho-McNeil Pharmaceutical, Inc. v. [read post]
3 Jun 2009, 5:49 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Singulair (Montelukast) – US: Merck & Co’s Singulair patent challenged on $50K bounty (Patent Baristas) (GenericsWeb) General Docs at BIO (Panel addresses narrowing scope of biotech patents – Patent Docs), (‘Perfect storm’ super session – Patent Docs) (Biotech… [read post]
24 Apr 2024, 4:52 am
For example, Mylan and Mallinckrodt settled significant cases alleging Medicaid rebate fraud brought by our whistleblower clients. [read post]
20 May 2013, 11:52 pm
Mylan concerning fexofenadine.The decision is by a 2-1 vote.The initial part of the decision:Aventis Pharmaceuticals, Inc. and Albany MolecularResearch, Inc. [read post]
10 Jul 2020, 2:08 pm
Mylan Pharm., Inc., No.cv-19-2216-RGA, 2019 WL 6910264, at *1 (D. [read post]
4 Aug 2015, 11:27 am
Mylan Labs., Inc., 464F.3d 1286, 1289 (Fed. [read post]
